ES300814A1 - Un procedimiento para la prepación de compuestos esteroides - Google Patents

Un procedimiento para la prepación de compuestos esteroides

Info

Publication number
ES300814A1
ES300814A1 ES300814A ES300814A ES300814A1 ES 300814 A1 ES300814 A1 ES 300814A1 ES 300814 A ES300814 A ES 300814A ES 300814 A ES300814 A ES 300814A ES 300814 A1 ES300814 A1 ES 300814A1
Authority
ES
Spain
Prior art keywords
translation
preparation
machine
legally binding
*** translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES300814A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES300814A1 publication Critical patent/ES300814A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Combinations Of Kitchen Furniture (AREA)
  • Insulated Conductors (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES300814A 1963-06-11 1964-06-10 Un procedimiento para la prepación de compuestos esteroides Expired ES300814A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB23223/63A GB1047518A (en) 1963-06-11 1963-06-11 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB362364 1964-01-28

Publications (1)

Publication Number Publication Date
ES300814A1 true ES300814A1 (es) 1964-12-01

Family

ID=26238483

Family Applications (2)

Application Number Title Priority Date Filing Date
ES300814A Expired ES300814A1 (es) 1963-06-11 1964-06-10 Un procedimiento para la prepación de compuestos esteroides
ES300811A Expired ES300811A1 (es) 1963-06-11 1964-06-10 Un procedimiento para la prepación de compuestos esteroides

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES300811A Expired ES300811A1 (es) 1963-06-11 1964-06-10 Un procedimiento para la prepación de compuestos esteroides

Country Status (14)

Country Link
US (1) US3312590A (es)
BE (2) BE649170A (es)
BR (2) BR6459937D0 (es)
CH (2) CH457422A (es)
CY (1) CY544A (es)
DE (2) DE1443958B1 (es)
DK (2) DK116128B (es)
ES (2) ES300814A1 (es)
FR (1) FR4548M (es)
GB (1) GB1047518A (es)
MY (1) MY7000131A (es)
NL (2) NL141378B (es)
NO (2) NO125532B (es)
SE (2) SE313562B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3475466A (en) * 1965-08-30 1969-10-28 Schering Corp Novel 17,21-diesters of 16alpha-methyl-9alpha,11beta-dichloro-1,4- pregnadienes
US3422193A (en) * 1966-08-11 1969-01-14 Schering Corp 17-mono esters of corticoids
IT1061787B (it) * 1967-03-01 1983-04-30 Vismara Francesco Spa Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
GB1281689A (en) * 1968-10-14 1972-07-12 Glaxo Lab Ltd Steroid 21-phosphates
US3694471A (en) * 1970-06-08 1972-09-26 Warner Lambert Pharmaceutical 17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent
DK135267A (es) * 1971-02-25
US3789121A (en) * 1971-11-26 1974-01-29 Warner Lambert Co 17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
DE2645104C2 (de) * 1976-10-04 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
JPS6040439B2 (ja) * 1978-03-29 1985-09-11 大正製薬株式会社 ヒドロコルチゾン誘導体
EP0029924B1 (en) * 1979-11-16 1984-08-15 STEROSYNT Ltd. 6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
US4350690A (en) * 1980-10-27 1982-09-21 Cressington Investments Ltd. Steroid composition
US4346086A (en) * 1981-06-09 1982-08-24 Beiersdorf Aktiengesellschaft Corticosteroid-containing cream
IL66432A0 (en) * 1981-08-04 1982-12-31 Plurichemie Anstalt Process for the preparation of steroidal esters
DE3133081A1 (de) * 1981-08-18 1983-03-10 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
FR2515041A1 (fr) * 1981-10-26 1983-04-29 Besins Jean Medicament a base de progesterone pour le traitement des affections mammaires
EP0095894A3 (en) * 1982-05-31 1985-01-02 Ohta Seiyaku Kabushiki Kaisha. 6 alpha-methylprednisolone derivatives
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3243482A1 (de) * 1982-11-22 1984-05-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
US4482539A (en) * 1983-05-13 1984-11-13 Schering Corporation Betamethasone dipropionate cream
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
DE3400188A1 (de) * 1984-01-02 1985-07-11 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 6(alpha),16(alpha)-dimethylkortikoide
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
YU48707B (sh) * 1990-03-02 1999-07-28 Glaxo Group Limited Aparat za inhaliranje - inhalator
SK280967B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Inhalačný prístroj
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
OA12394A (en) * 2000-08-05 2004-07-09 Glaxo Group Ltd 6.Alpha-,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fuoromethyl ester as an anti-inflammatory agent.
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
EP2039700A2 (en) * 2001-04-30 2009-03-25 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
ATE399174T1 (de) * 2001-06-12 2008-07-15 Glaxo Group Ltd Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
WO2003048181A1 (en) * 2001-12-01 2003-06-12 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Ｉｖ型ホスホジエステラーゼの阻害剤
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20110021473A1 (en) * 2006-09-22 2011-01-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
US8796248B2 (en) 2007-10-05 2014-08-05 Nektar Therapeutics Oligomer-corticosteroid conjugates
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN112358522B (zh) * 2020-05-18 2021-11-16 河南利华制药有限公司 一种倍他米松二丙酸酯的精制方法及倍他米松二丙酸酯
CN111944002A (zh) * 2020-07-29 2020-11-17 河南利华制药有限公司 一种倍氯米松二丙酸酯中间体及制备方法
CN116023425B (zh) * 2023-03-28 2023-06-20 南京师范大学 曲安西龙衍生物及其医药用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147249A (en) * 1961-06-13 1964-09-01 Vismara Francesco Spa 17alpha, 21-substituted methylenedioxy steroids and methods therefor
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden

Also Published As

Publication number Publication date
BE649171A (es) 1964-12-11
NL141378B (nl) 1974-03-15
SE313562B (es) 1969-08-18
ES300811A1 (es) 1962-12-16
NO125532B (es) 1972-09-25
DE1443957B1 (de) 1970-01-02
CH457422A (de) 1968-06-15
CY544A (en) 1970-07-02
MY7000131A (en) 1970-12-31
DE1443958B1 (de) 1970-01-02
DK116128B (da) 1969-12-15
BR6459937D0 (pt) 1973-08-07
FR4548M (es) 1966-11-02
BE649170A (es) 1964-12-11
GB1047518A (en) 1966-11-02
NL142157B (nl) 1974-05-15
NL6406614A (es) 1964-12-14
CH450410A (de) 1968-01-31
SE320066B (es) 1970-02-02
BR6459936D0 (pt) 1973-08-02
NL6406615A (es) 1964-12-14
US3312590A (en) 1967-04-04
NO125533B (es) 1972-09-25
DK116205B (da) 1969-12-22

Similar Documents

Publication Publication Date Title
ES300814A1 (es) Un procedimiento para la prepación de compuestos esteroides
ES299652A1 (es) Un procedimiento para la preparación de compuestos esteroides
ES417737A1 (es) Procedimiento para la preparacion de esteroides de la seriedel pregnano.
ES311323A1 (es) Procedimiento para la preparacion de acetilencarbinoles.
ES299417A1 (es) Procedimiento para la preparación de fluoropirimidinas
ES281669A1 (es) Un procedimiento para preparar una cetona esteroide
ES400056A1 (es) Procedimiento para la preparacion de nuevos 16 alfa, 16 al-fa-metilenesteroides.
GB983125A (en) Preparation of 9(11)-dehydro spirostanes and 3-esters thereof
ES306437A1 (es) Un procedimiento para la preparacion de 3-espiro-3-diazirinaesteroides o 3-espiro-3-diaziridina esteroides.
GB1047790A (en) Improvements in or relating to steroid compounds
ES255422A1 (es) Procedimiento para la obtenciën de nuevos esteroides intermedios
ES289782A1 (es) Procedimiento para preparar 1-amino-2-arilloxi-4-hidroxiantraquinonas
ES361606A1 (es) Procedimiento para la preparacion de nuevos derivados 5-ni-trofurilicos.
ES286297A2 (es) Un procedimiento de preparación de estradiol
ES295424A1 (es) Procedimiento para la preparaciën de nuevos 16-alquil-esteroides de la clase del pregnano
ES223080A1 (es) PROCEDIMIENTO PARA LA SiNTESIS DE ESTEROIDES
ES226011A3 (es) Un procedimiento para la producción de compuestos de estradiol.
ES334936A1 (es) Procedimiento de deshidrohalogenacion para la preparacion de gonenos sinteticos.
ES305107A1 (es) Procedimiento para preparar una composicion que contiene un compuesto organotiofosforoso estabilizado en cuanto al olor.
ES447640A1 (es) Un procedimiento para preparar 3-amino-1-alfa-carboxi-4-hi- droxibencil)-2-azetidinona.
ES287011A1 (es) Procedimiento para la preparación de 3-enolacilatos de esteroide
ES331808A1 (es) Un procedimiento para preparar un tiocetal.
ES387315A1 (es) Procedimiento para la obtencion de 17-monoesteres de este- roides dihidroxilados en c17 y c21.
ES316376A1 (es) Un procedimiento para la preparacion de 3-espiro-3-diazirinaesteroides.
ES264430A1 (es) Un procedimiento de derivados de preparaciën del bishidroximetileno pregnano